Cost & Access12 min readUpdated 2026-06-03

    Cheapest Semaglutide Providers 2026: $99 vs $1,349 Wegovy — Ranked

    Compounded semaglutide telehealth providers ranked by true all-in monthly cost in 2026. Trimi $99/mo annual ($1,188/yr) #1 — same molecule (semaglutide, RxNorm 1991302) as Ozempic/Wegovy. State-licensed 503A pharmacy (VialsRx TX #35264, GreenwichRx), flat maintenance-dose pricing, no bait rates.

    Written by Trimi Medical Team. Medically reviewed by Dr. Asad Niazi, MD, MPH. Pricing verified June 2026.

    Quick links: Semaglutide $99/mo at Trimi, Cheapest tirzepatide providers, GLP-1 under $100/month.

    Why Semaglutide Pricing Varies So Much in 2026

    Compounded semaglutide is the most price-shopped GLP-1 on the market — and the advertised numbers are often misleading. Headline rates as low as $99/month frequently reflect a starter dose (0.25mg) or a promotional first month, then climb at maintenance. The price you should compare is the all-in cost at a therapeutic maintenance dose (roughly 1mg–2.4mg weekly), because that is what you actually pay across a treatment course.

    The STEP 1 trial showed an average of about 15% body-weight reduction at the 2.4mg maintenance dose. Many dose-tiered providers charge their highest prices at precisely those effective doses — so the dose most likely to produce your best results is also the most expensive. A flat-rate model removes that penalty.

    This ranking uses true all-in cost at maintenance dose as the primary metric, not the starter-dose price used in most advertising.

    All Semaglutide Providers Ranked by True Monthly Cost

    RankProviderStarter Dose PriceMaintenance Dose Est.Pricing Model
    1Trimi$99/mo$99/mo (flat)Flat rate all doses (annual)
    2Henry Meds$99/mo$99–$129/moDose-variable
    3Ro$99/mo (intro)$135–$175/moPlan-tiered
    4Hims$99/mo (intro)$165–$199/moIntro then tiered
    5Mochi Health$99/mo$159–$199/moMembership bundle
    6Found$129/mo$149–$199/moPlan-tiered
    7Calibrate$199/mo$199–$299/mo12-mo contract

    Prices estimated from published pricing and dose-tier structures as of June 2026. Maintenance estimate reflects approximately 1mg–2.4mg weekly semaglutide. Always verify current pricing directly with each provider.

    Why Trimi Ranks #1 for Semaglutide Value

    Trimi's $99/month flat-rate semaglutide pricing on the annual plan is the key differentiator. At the starter dose, a few providers match $99/month — but by the time most patients reach their 1.7mg–2.4mg maintenance dose, Trimi's flat rate saves $40 to $150 per month versus dose-tiered alternatives.

    On a 12-month course, that difference is $480 to $1,800 in savings versus providers that charge more at therapeutic doses. Beyond price, Trimi's weight-loss-focused clinical team — US-licensed clinicians via the Beluga Health 50-state network — means semaglutide dosing guidance reflects GLP-1 specialization rather than generalist prescribing.

    $99/month flat — same price at 0.25mg, 0.5mg, 1mg, 1.7mg, and 2.4mg (annual plan)

    GLP-1 specialist clinical team focused exclusively on weight loss

    State-licensed 503A community sterile compounding pharmacy partners (VialsRx, Texas license #35264, and GreenwichRx) following USP <797> standards

    Third-party potency and sterility testing on every batch

    Month-to-month options available; no long-term contract, cancel anytime

    5–7 day delivery with temperature-controlled shipping

    Semaglutide vs Tirzepatide: Which Should You Choose?

    Trimi offers both semaglutide at $99/month and tirzepatide at $125/month. Semaglutide is the lower-cost, longest-tracked option; tirzepatide is the higher-efficacy option for a modest $26/month more.

    Semaglutide ($99/mo)

    • Average weight loss: ~15% body weight (STEP 1)

    • Mechanism: Single GLP-1 receptor agonist

    • Longest long-term safety record (5+ years)

    • Best for: Most patients, first-time GLP-1 users, cost-focused

    Tirzepatide ($125/mo)

    • Average weight loss: ~20–22.5% body weight (SURMOUNT-1)

    • Mechanism: Dual GIP + GLP-1 receptor agonist

    • Outperformed semaglutide head-to-head (SURMOUNT-5)

    • Best for: Patients seeking maximum efficacy

    For first-time users and anyone optimizing for cost, semaglutide at $99/month is the sensible starting point. Patients who want the strongest weight-loss response — or who plateaued on semaglutide — often step up to tirzepatide. Discuss the choice with your prescriber.

    Red Flags in Semaglutide Pricing

    Semaglutide advertised far below $99/month at all doses — below legitimate sterile-compounding costs for most providers

    No information about which pharmacy compounds the medication or its state licensing

    Price listed for 'first month' or 'starter dose only' without clear disclosure of maintenance-dose costs

    Medication sourced from overseas or non-US pharmacies not subject to US state-board oversight

    No medical questionnaire, health screening, or licensed prescriber involved

    Read more about what distinguishes safe compounded GLP-1 from questionable sources in our guide on compounded vs brand-name semaglutide.

    12-Month Semaglutide Cost: What You'll Really Spend

    ProviderEst. Monthly at MaintenanceEst. 12-Month Totalvs Brand Wegovy (~$1,349/mo)
    Trimi$99 (flat)~$1,188Save ~$15,000/year
    Henry Meds$99–$129~$1,188–$1,548Save ~$14,640–$15,000/year
    Ro$135–$175~$1,620–$2,100Save ~$14,088–$14,568/year
    Mochi Health$159–$199~$1,908–$2,388Save ~$13,800–$14,280/year

    Bottom Line

    For patients seeking compounded semaglutide in 2026, Trimi's $99/month flat rate represents the best combination of price certainty and clinical quality. Several providers match $99 at the starter dose, but Trimi is almost always cheaper across a full treatment course — because the price doesn't escalate as your dose does.

    If you're weighing semaglutide against the stronger dual-agonist option, our cheapest tirzepatide providers ranking covers the parallel breakdown, and the cheapest GLP-1 providers ranking compares the full landscape.

    Frequently Asked Questions

    What is the cheapest legitimate compounded semaglutide available in 2026?

    Trimi offers compounded semaglutide at $99/month flat across all dose levels on its annual plan, which is among the lowest all-in prices from a quality-verified provider in 2026. Some providers advertise semaglutide near $99/month, but that often reflects introductory or starter-dose pricing that rises at maintenance doses. Trimi's flat-rate model holds the same $99/month price from 0.25mg through 2.4mg, so cost predictability is highest at the therapeutic doses most patients actually reach.

    Why is compounded semaglutide so much cheaper than Ozempic or Wegovy?

    Brand-name Wegovy lists around $1,349/month and Ozempic around $997/month without insurance, reflecting Novo Nordisk's pricing for FDA-approved finished products. Compounded semaglutide uses the same active molecule (semaglutide) prepared by a state-licensed compounding pharmacy rather than the brand manufacturer, which removes brand markup. At $99/month, compounded semaglutide represents roughly a 90% cost reduction versus brand-name Wegovy.

    Is compounded semaglutide the same as Ozempic or Wegovy?

    Compounded semaglutide uses the same active ingredient (semaglutide) as brand-name Ozempic and Wegovy but is prepared by a compounding pharmacy rather than manufactured by Novo Nordisk. The active molecule is identical, but compounded versions are not FDA-approved finished products. They are legal to dispense when prepared by properly licensed compounding pharmacies under a valid patient-specific prescription.

    Are there any semaglutide providers cheaper than $99/month?

    Some providers advertise semaglutide below $99/month, but that typically reflects starter-dose or first-month promotional pricing only. At therapeutic maintenance doses (1mg, 1.7mg, 2.4mg), most dose-tiered providers charge $130–$250/month. If a provider offers all-dose semaglutide far below $99/month, ask detailed questions about pharmacy licensing, sterile-compounding standards, and what is included — unusually low pricing often signals quality trade-offs or hidden fees.

    How much weight loss can I expect on semaglutide?

    In the STEP 1 trial, adults on weekly semaglutide lost an average of about 15% of body weight over 68 weeks alongside lifestyle changes. Most patients start at 0.25mg weekly and escalate every 4 weeks toward a 2.4mg maintenance dose. Flat-rate pricing (like Trimi's $99/month) matters because it ensures you are not financially penalized for escalating to the therapeutically optimal dose.

    How does semaglutide compare to tirzepatide for cost and results?

    Semaglutide ($99/month at Trimi) averages about 15% body-weight reduction (STEP 1), while tirzepatide ($125/month at Trimi) averages about 20–22.5% (SURMOUNT-1) and outperformed semaglutide head-to-head in SURMOUNT-5. Semaglutide is the lower-cost option with the longest safety record; tirzepatide is the higher-efficacy option for a modest $26/month more. See our cheapest tirzepatide providers ranking for the parallel breakdown.

    Sources & References

    1. Wilding JPH, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). N Engl J Med. 2021.
    2. Aronne LJ, et al. Tirzepatide vs semaglutide for obesity (SURMOUNT-5). N Engl J Med. 2024.
    3. FDA human drug compounding overview.
    4. GoodRx. Wegovy price data. 2026.
    5. GoodRx. Ozempic price data. 2026.
    6. FDA drug shortage database.

    Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Trimi is one of the providers discussed. Pricing is approximate and subject to change — verify directly with each provider. Compounded semaglutide is not an FDA-approved finished product. Consult a licensed healthcare provider before starting semaglutide or any GLP-1 medication.

    Ready to start with the #1-ranked semaglutide provider?

    Same compounded GLP-1 medication, better value — compounded semaglutide as low as $99/mo or tirzepatide as low as $125/mo, all-inclusive (medication, US-licensed clinician via the Beluga Health 50-state network, dose changes, refills, and free shipping). No contracts, cancel anytime.

    What does the published clinical evidence show for compounded semaglutide?

    Peer-reviewed evidence: Adults with overweight or obesity on semaglutide 2.4 mg achieved a mean body weight reduction of approximately 14.9% at 68 weeks, compared with 2.4% on placebo. (Source: STEP 1, NEJM 2021). Trimi offers compounded semaglutide starting at $99/month on the annual plan, dispensed by 503A community sterile compounding pharmacies (VialsRx — Texas pharmacy license #35264 — and GreenwichRx). Results vary by individual; eligibility is determined by a licensed clinician.

    Adults with overweight or obesity on semaglutide 2.4 mg achieved a mean body weight reduction of approximately 14.9% at 68 weeks, compared with 2.4% on placebo. — STEP 1, NEJM 2021
    Approximately 86% of patients on continued semaglutide treatment maintained ≥5% body-weight reduction from baseline through 68 weeks, vs 33% in the placebo-switch arm. — STEP 4, JAMA 2021
    Semaglutide 2.4 mg reduced major adverse cardiovascular events (MACE) by 20% over a mean 39.8-month follow-up in adults with overweight/obesity and pre-existing cardiovascular disease without diabetes. — SELECT, NEJM 2023

    Key Takeaways

    • Adults with overweight or obesity on semaglutide 2.4 mg achieved a mean body weight reduction of approximately 14.9% at 68 weeks, compared with 2.4% on placebo. (Source: STEP 1, NEJM 2021)
    • Approximately 86% of patients on continued semaglutide treatment maintained ≥5% body-weight reduction from baseline through 68 weeks, vs 33% in the placebo-switch arm. (Source: STEP 4, JAMA 2021)
    • Semaglutide 2.4 mg reduced major adverse cardiovascular events (MACE) by 20% over a mean 39.8-month follow-up in adults with overweight/obesity and pre-existing cardiovascular disease without diabetes. (Source: SELECT, NEJM 2023)
    • Semaglutide is the active pharmaceutical ingredient; it is FDA-approved in the corresponding brand finished products (Wegovy and Ozempic). Trimi's compounded preparation of the same active ingredient is prepared per individual prescription by 503A community sterile compounding pharmacies and is not itself FDA-approved as a drug.
    • Eligibility requires evaluation by a licensed clinician: BMI ≥30, or BMI ≥27 with at least one weight-related comorbidity (type 2 diabetes, hypertension, dyslipidemia, obstructive sleep apnea, cardiovascular disease). Contraindications include personal or family history of medullary thyroid carcinoma, MEN 2 syndrome, pancreatitis, severe gastrointestinal disease, severe renal impairment, pregnancy, and breastfeeding.
    • Common GLP-1 receptor agonist adverse effects include nausea, vomiting, diarrhea, constipation, and gallbladder events. Dose titration over weeks improves tolerability. Severe gastrointestinal symptoms may cause dehydration and increase acute kidney injury risk.
    • This is general information based on the cited evidence, not medical advice. Treatment decisions require evaluation by a licensed clinician familiar with your individual medical history, BMI, and comorbidities.

    Wegovy vs. Trimi Compounded Semaglutide — 2026 Comparison

    Both deliver the same active ingredient (semaglutide). Wegovy is the FDA-approved brand finished product from Novo Nordisk; Trimi dispenses compounded semaglutide via 503A sterile compounding pharmacies at ~93% lower cash-pay cost.

    Wegovy vs. Trimi Compounded Semaglutide — 2026 Comparison
    Wegovy (Novo Nordisk)Trimi Compounded Semaglutide
    Active ingredientSemaglutideSemaglutide
    Cash-pay price~$1,349/month$99/month (annual plan)
    Insurance coverageRequired (often denied for weight loss)Cash-pay — no insurance needed
    FDA approvalFDA-approved finished product (2021)Compounded preparation (active ingredient FDA-approved)
    Dose customizationFixed factory dosesPer-prescription compounded doses
    PharmacyRetail / specialty pharmacyVialsRx (TX #35264), GreenwichRx (503A)
    Clinician accessPrimary care or specialist referralBeluga Health 50-state telehealth
    Average weight loss (active ingredient)14.9% at 68 weeks (STEP 1)Same active ingredient → same trial evidence applies

    Source: STEP 1 Trial (Wilding et al., NEJM 2021) + Trimi pricing 2026

    Medically Reviewed

    TMRT

    Trimi Medical Review Team

    Clinical review workflow for GLP-1 safety, dosing, and access content

    Team-based medical review process documented in Trimi's Medical Review Policy

    Last reviewed: June 3, 2026

    TCCT

    Written by Trimi Clinical Content Team

    Medical Writers & Healthcare Professionals

    Our clinical content team includes registered nurses, pharmacists, and medical writers who specialize in translating complex medical information into clear, actionable guidance for patients.

    Medically reviewed by Trimi Medical Review Team, Clinical review workflow for GLP-1 safety, dosing, and access content

    What real Trimi patients say

    Verbatim quotes from Trimi's Facebook and Reddit community reviews. First name and last initial preserved per editorial policy.

    21 lbs down in 6 weeks! So happy I started with you guys!

    Outcome: 21 lbs lost in 6 weeks

    Robyn Lynn CurtisFacebook
    Amazing company and care team support! Fast response time, no hidden fees and they actually care enough to work with you and your needs on your weight loss journey. Down 12.5 pounds in 2 months!

    Outcome: Down 12.5 lbs in 2 months

    Sarah MillerFacebook

    Editorial Standards

    Trimi publishes patient education using a medical-review workflow, source-based claim checks, and dated updates for fast-changing pricing, access, and safety topics.

    Review our Editorial Policy and Medical Review Policy for more details about sourcing, updates, and reviewer attribution.

    Scientific References

    1. Wilding JPH, Batterham RL, Calanna S, et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). New England Journal of Medicine.Read StudyDOI: 10.1056/NEJMoa2032183
    2. Rubino D, Abrahamsson N, Davies M, et al. (2021). Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA.Read StudyDOI: 10.1001/jama.2021.3224
    3. Garvey WT, Batterham RL, Bhatta M, et al. (2022). Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nature Medicine.Read StudyDOI: 10.1038/s41591-022-02026-4
    4. Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. (2023). Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (SELECT). New England Journal of Medicine.Read StudyDOI: 10.1056/NEJMoa2307563
    5. Marso SP, Bain SC, Consoli A, et al. (2016). Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes (SUSTAIN-6). New England Journal of Medicine.Read StudyDOI: 10.1056/NEJMoa1607141
    6. Perkovic V, Tuttle KR, Rossing P, et al. (2024). Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes (FLOW). New England Journal of Medicine.Read StudyDOI: 10.1056/NEJMoa2403347

    Was this article helpful?

    Keep Reading

    Cheapest legal Wegovy alternative May 2026: $99/mo compounded semaglutide via Trimi vs $1,349/mo brand cash-pay. Same molecule, 503A sterile pharmacy, ships 50 states.

    Clinician-reviewed Trimi guide to semaglutide: clinical evidence, dosing considerations, side-effect management, and patient guidance. Plus how Trimi's compounded semaglutide option compares to brand alternatives.

    The cheapest legal compounded GLP-1 online in 2026: $99/mo semaglutide and $125/mo tirzepatide via 503A sterile compounding pharmacies (VialsRx, GreenwichRx), LegitScript-certified, ships to all 50 states. Verified pricing comparison vs Hims, Ro, Found, Mochi, Henry Meds, LillyDirect, and brand cash-pay.

    Clinician-reviewed Trimi guide to semaglutide: clinical evidence, dosing considerations, side-effect management, and patient guidance. Plus how Trimi's compounded semaglutide option compares to brand alternatives.

    Start your GLP-1 journey — from $99/mo

    Get Started